The Johns Hopkins University
UEI FTMTDMBR29C7 · MD · subsidiary of The Johns Hopkins Health System Corporation · SAM.gov record ↗
$35.6M
FY2025 obligations
126
Contract awards
Sep 30, 2014
First action
Sep 29, 2025
Latest action
Obligations by agency
- Department Of Health And Human Services$20.5M
- Department Of Defense$10.6M
- Department Of Homeland Security$2.2M
- General Services Administration$1.8M
- Department Of Justice$417K
- Department Of Veterans Affairs$5K
Obligations by NAICS
Monthly obligations
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Contracts ending within 18 months (recompete watch)
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N93023F00004 ↗ | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI FULL TERMINATION | National Institutes Of Health | 541714 | $0 | Aug 23, 2023 | Jul 22, 2026 |
| 75N94020F00001 ↗ | EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI NICHD: SERVICE: CORE FUNCTION ACTIVITIES: SEVERABLE: BILATERAL MODIFICATION TO DESCOPE | National Institutes Of Health | 541714 | $3K | Aug 1, 2020 | Jul 31, 2026 |
| 75N93024F00001 ↗ | OPERATION OF A FACILITY FOR THE STUDY OF INFECTIOUS AGENTS, VACCINES AND ANTIVIRALS IN ADULT AND PEDIATRIC HUMAN SUBJECTS FOR NIAID | National Institutes Of Health | 541714 | $0 | Oct 25, 2023 | Aug 1, 2026 |
| 75N93023F00002 ↗ | PHASE I STUDY OF THE INFECTIVITY, SAFETY AND IMMUNOGENICITY OF TWO RECOMBINANT, LIVE-ATTENUATED, BOVINE/HUMAN, PARAINFLUENZA VIRUS TYPE 3 (B/HPIV3) VECTOR VACCINES EXPRESSING THE FUSION GLYCOPROTEIN OF HUMAN METAPNEUMOVIRUS, DELIVERED BY NASAL SPRAY | National Institutes Of Health | 541714 | $0 | May 5, 2023 | Aug 1, 2026 |
| 75F40124C00084 ↗ | PREDICTION OF PESTICIDES IN FOODS USING HIGH RESOLUTION MASS SPECTROMETRY AND ARTIFICIAL INTELLIGENCE/MACHINE LEARNING WORKFLOWS FOR ENFORCEMENT AND RISK ASSESSMENT | Food And Drug Administration | 541715 | $162K | Aug 27, 2024 | Aug 26, 2026 |
| HDTRA123C0050 ↗ | POSTDOCTORAL SCHOLARS PROGRAM SPT, BASE INCREMENTAL FUNDING FOR CLIN 0001 | Defense Threat Reduction Agency | 611310 | $1.5M | Sep 1, 2023 | Aug 31, 2026 |
| 75N92025P00343 ↗ | GENETIC COUNSELING TRAINING, NEW PO | National Institutes Of Health | 611430 | $40K | Sep 1, 2025 | Aug 31, 2026 |
| 70US0925C70093550 ↗ | THE PURPOSE OF THIS CONTRACT IS TO PROVIDE ACADEMIC MEDICAL SUPPORT SERVICES TO PROVIDE CARE TO THE SECRET SERVICES PROTECTEES, EMPLOYEES, AND MEMBERS OF THE PUBLIC. | U.S. Secret Service | 621111 | $1.2M | Sep 8, 2025 | Sep 7, 2026 |
| 36C24E24C0014 ↗ | RESEARCH SERVICES - FINITE ELEMENT MODELING OF EYE | Department Of Veterans Affairs | 611310 | $63K | Sep 18, 2024 | Sep 17, 2026 |
| 75N95024P00592 ↗ | EOI::IMPLEMENTING THE PRESIDENT'S DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI CUSTOM RADIOSYNTHESIS OF PET LIGANDS AND USE OF PET FACILITY. POP: SEPTEMBER 20, 2024 - SEPTEMBER 19, 2026. | National Institutes Of Health | 541690 | $116K | Sep 20, 2024 | Sep 19, 2026 |
Largest awards
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| FA251822C0010 ↗ | GUARDIAN EDUCATION CANDIDATE SCHOOL | Department Of The Air Force | 611310 | $6.8M | Sep 23, 2022 | Jun 30, 2026 |
| 75N92025F00003 ↗ | HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE | National Institutes Of Health | 541715 | $5.3M | Sep 26, 2025 | Sep 25, 2028 |
| 75N93021C00045 ↗ | JOHNS HOPKINS UNIVERSITY CEIRR 75N93021C00045. THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR). | National Institutes Of Health | 541715 | $4.6M | Aug 1, 2021 | Jan 14, 2027 |
| 75N93020C00001 ↗ | PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES (SMILE) | National Institutes Of Health | 541715 | $2.7M | Nov 15, 2019 | Nov 14, 2025 |
| 75N92024F00001 ↗ | HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE - PROGRAM MANAGEMENT | National Institutes Of Health | 541715 | $2.6M | Jun 1, 2024 | May 31, 2026 |
| 47QFHA23C0005 ↗ | OUSD STRATEGIC THINKERS PROGRAM - FUNDING ACTION | Federal Acquisition Service | 611310 | $1.8M | Aug 1, 2023 | Jul 31, 2025 |
| HR001125C0304 ↗ | SCIENTIFIC FEASIBILITY (SCIFY) | Defense Advanced Research Projects Agency | 541715 | $1.6M | Dec 2, 2024 | Jan 31, 2026 |
| HDTRA123C0050 ↗ | POSTDOCTORAL SCHOLARS PROGRAM SPT, BASE INCREMENTAL FUNDING FOR CLIN 0001 | Defense Threat Reduction Agency | 611310 | $1.5M | Sep 1, 2023 | Aug 31, 2026 |
| 75N98022D00057 ↗ | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OY3, PARTIAL DESCOPE IAW HCEI, AND CLARIFY LINE ITEMS | National Institutes Of Health | 541990 | $1.3M | Sep 1, 2022 | — |
| 70US0925C70093550 ↗ | THE PURPOSE OF THIS CONTRACT IS TO PROVIDE ACADEMIC MEDICAL SUPPORT SERVICES TO PROVIDE CARE TO THE SECRET SERVICES PROTECTEES, EMPLOYEES, AND MEMBERS OF THE PUBLIC. | U.S. Secret Service | 621111 | $1.2M | Sep 8, 2025 | Sep 7, 2026 |
| 75F40125C00054 ↗ | THE FOOD AND DRUG ADMINISTRATION?S CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) BIOLOGICS EFFECTIVENESS AND SAFETY INNOVATIVE METHODS (BEST IM) PROGRAM ENHANCES THE SAFETY OF VACCINES, BLOOD PRODUCTS, AND BIOLOGICS THROUGH HIGH-QUALITY ANALY | Food And Drug Administration | 541714 | $1.1M | Sep 10, 2025 | Sep 29, 2027 |
| 75N92022F00001 ↗ | THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A | National Institutes Of Health | 541715 | $936K | Nov 15, 2021 | Nov 14, 2025 |
| 70US0923C70093331 ↗ | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE ADDITIONAL PHYSICIAN SUPPORT PER THE ATTACHED REVISED STATEMENT OF WORK; FOR MEDICAL SUPPORT FOR CAMPAIGN NOMINEE OPERATIONS SECTION (CNOS) FROM NOVEMBER 11, 2024 THROUGH JANUARY 19, 2025. | U.S. Secret Service | 621111 | $932K | Aug 31, 2023 | Sep 29, 2025 |
| 75H70425P00020 ↗ | TRAINING TO INCREASE IMMUNIZATION ASSURANCE IN INDIGENOUS COMMUNITIES | Indian Health Service | 611710 | $495K | Jun 11, 2025 | Jun 12, 2026 |
| 75N92025F00001 ↗ | MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) | National Institutes Of Health | 541715 | $443K | Apr 12, 2025 | Dec 18, 2025 |
| 75N92025F00001 ↗ | THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER | National Institutes Of Health | 541715 | $442K | Jan 1, 2025 | Dec 31, 2025 |
| 75N92025F00002 ↗ | HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE: WHOLE GENOME SEQUENCING FOR COZEN (NCI) | National Institutes Of Health | 541715 | $317K | Jul 17, 2025 | Jul 16, 2027 |
| 75N95025P00294 ↗ | CLINICAL SERVICES AND RESOURCES FOR THE NATIONAL INSTITUTE ON DRUG ABUSE (NIDA) INTRAMURAL RESEARCH PROGRAM (IRP). 7/1/2025-12/31/2025. | National Institutes Of Health | 622110 | $275K | Jul 1, 2025 | Dec 31, 2025 |
| 75N92025F00001 ↗ | MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), FIELD CENTER (FC): TASK A - CORE OPERATIONS | National Institutes Of Health | 541715 | $270K | Dec 19, 2024 | Apr 11, 2025 |
| 15A00025FAQ000067 ↗ | MEDIC SUPPORT SERVICES | Bureau Of Alcohol, Tobacco, Firearms And Explosives Acquisition And Property Management Division | 541990 | $268K | Mar 19, 2025 | Mar 19, 2026 |
| 75N92025F00001 ↗ | HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE: WHOLE GENOME SEQUENCING FOR BEEBE-DIMMER (NCI) | National Institutes Of Health | 541715 | $263K | Jul 17, 2025 | Jul 16, 2027 |
| N0024425FS009 ↗ | JOHN HOPKINS UNIVERSITY TUITION AND FEES | Department Of The Navy | 611310 | $221K | May 9, 2025 | Jun 15, 2025 |
| FA865021C2411 ↗ | CUSTOM SYNTHETIC ENDOTHERMIC FUEL | Department Of The Air Force | 541715 | $211K | Oct 14, 2022 | Mar 31, 2026 |
| 75N93025P01100 ↗ | ACQUISITION OF MACCA NEMESTRINA (PIGTAILED MACAQUE) | National Institutes Of Health | 611310 | $195K | Sep 29, 2025 | Jan 1, 2026 |
| 75D30123F00001 ↗ | CLINICAL IMMUNZATION SAFETY ASSESSMENT (CISA) CLINICAL VACCINE SAFETY EVALUATION | Centers For Disease Control And Prevention | 611210 | $188K | Sep 26, 2023 | Sep 27, 2026 |